Bioinformatics Analysis and Experimental Validation of <scp>ASF1B</scp> in Breast Tumors
ASF1B is highly expressed in breast cancer and correlates with poor prognosis and immune cell infiltration. It may serve as a potential prognostic biomarker and therapeutic target in breast cancer.
Authors
- Meng Deng (ORCID: https://orcid.org/0000-0002-9051-7534)
- Xuefang Mi
- Wendong Wang (ORCID: https://orcid.org/0000-0002-8631-3109)
- Huixia Li (ORCID: https://orcid.org/0000-0003-2410-2485)
- Xin Ge (ORCID: https://orcid.org/0000-0001-8438-802X)
- Yueqi Liu (ORCID: https://orcid.org/0000-0001-6027-5960)
- Wen Xing
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71073
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zhengzhou University
- First Affiliated Hospital of Zhengzhou University